NZ337927A - Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds - Google Patents

Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds

Info

Publication number
NZ337927A
NZ337927A NZ337927A NZ33792798A NZ337927A NZ 337927 A NZ337927 A NZ 337927A NZ 337927 A NZ337927 A NZ 337927A NZ 33792798 A NZ33792798 A NZ 33792798A NZ 337927 A NZ337927 A NZ 337927A
Authority
NZ
New Zealand
Prior art keywords
tetrahydro
benzoic acid
tetramethyl
naphthyloxy
methyl
Prior art date
Application number
NZ337927A
Other languages
English (en)
Inventor
Magnus Pfahl
Waldemar Lernhardt
Andrea Fanjol
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NZ337927A publication Critical patent/NZ337927A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Physical Vapour Deposition (AREA)
NZ337927A 1997-03-24 1998-03-24 Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds NZ337927A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3560497P 1997-03-24 1997-03-24
PCT/US1998/005591 WO1998042340A1 (en) 1997-03-24 1998-03-24 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
NZ337927A true NZ337927A (en) 2000-11-24

Family

ID=21883695

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ337927A NZ337927A (en) 1997-03-24 1998-03-24 Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds

Country Status (11)

Country Link
EP (1) EP1019049A1 (xx)
JP (1) JP2001521551A (xx)
KR (1) KR20010005678A (xx)
CN (1) CN1256630A (xx)
AU (1) AU6576398A (xx)
BR (1) BR9808054A (xx)
CA (1) CA2284192A1 (xx)
IL (1) IL132032A0 (xx)
NO (1) NO994612L (xx)
NZ (1) NZ337927A (xx)
WO (1) WO1998042340A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR023700A1 (es) * 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
KR100643833B1 (ko) * 1998-11-12 2006-11-10 스미스클라인비이참피이엘시이 인슐린 감작제 및 다른 항당뇨병 약제의 개선된 방출을위한 제약 조성물
WO2002100396A1 (en) * 2001-06-07 2002-12-19 Wyeth COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT
CN1921843A (zh) * 2004-01-23 2007-02-28 独立行政法人科学技术振兴机构 含视黄酸的糖尿病治疗药
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
CA2937107C (en) 2014-01-17 2020-12-22 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04504847A (ja) * 1989-03-08 1992-08-27 ザ　ユニバーシティ　オヴ　バージニア　パテント　ファウンデーション インスリン抵抗性糖尿病のための食事用補添物
FR2695317B1 (fr) * 1992-09-07 1995-03-10 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
AU676227B2 (en) * 1993-01-22 1997-03-06 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Therapeutic agent for NIDDM
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5444086A (en) * 1994-03-31 1995-08-22 American Home Products Corporation Naphthalenylmethyl thiophenones as antihyperglycemic agents

Also Published As

Publication number Publication date
WO1998042340A1 (en) 1998-10-01
JP2001521551A (ja) 2001-11-06
CA2284192A1 (en) 1998-10-01
NO994612L (no) 1999-11-24
KR20010005678A (ko) 2001-01-15
BR9808054A (pt) 2000-11-07
CN1256630A (zh) 2000-06-14
IL132032A0 (en) 2001-03-19
NO994612D0 (no) 1999-09-22
AU6576398A (en) 1998-10-20
EP1019049A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
EP1121129B1 (en) METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS
KR100697582B1 (ko) 케톤증 개선제
WO1998005331A3 (en) Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
AU688739B2 (en) Method and composition for the treatment of Parkinson's disease
KR940006590A (ko) 알쯔하이머 질환 치료용 및 혈당저하제로서 유용한 화합물
NO314065B1 (no) Farmasöytisk sammensetning omfattende en insulinsensitivitetsenhancer og etbiguanid ved behandling av diabetes
AU4291499A (en) Pharmaceutical composition for the treatment of diabetes
KR940019699A (ko) 옥사졸리딘디온 유도체, 그의 제조방법 및 용도
MX9700763A (es) Procedimiento para la preparacion de benzoxazoles y derivados de piridinas utiles en el tratamiento de la diabetes del tipo ii, los benzoxazoles y derivados de piridina obtenidos, composiciones de los mismos y su uso.
EP0695183B1 (en) Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
EP1078923A3 (en) Process for the preparation of benzothiophene derivatives
CA2397294A1 (en) Glyburide composition
NZ337927A (en) Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds
NO322314B1 (no) Farmasoytisk preparat, sett som omfatter flere beholdere, samt anvendelse av troglitazon, pioglitazon og/eller BRL-49653 ved fremstilling av et medikament.
IL112590A (en) Insulin sensitisers for use in the treatment of renal diseases
JP2002508373A5 (xx)
EP0921798A1 (en) Novel treatment of leptine resistance
AP1441A (en) Hydrate of 5- [4-{2-(N-methlyl-N-(2-pyridil) amino) ethoxy} benzyl] thiazolidine-2,4-dione maleic acid salt.
EP1405848A4 (en) TETRAHYDROCHINOLINE DERIVATIVE COMPOUND AND THE COMPOUND OF AN ACTIVE MEDICAMENT CONTAINING ACTIVE SUBSTANCE
NZ513922A (en) Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione
JPS62132826A (ja) 抗高血圧剤
IE871766L (en) 4-(aroylamino)piperidinebutanamide derivatives
CO4940489A1 (es) Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos
BG103966A (bg) Лечение на диабет с тиазолидиндион и инхибитор наалфа глюкозидазата
RU99122356A (ru) Родственные ретиноиду молекулы для лечения инсулиннезависимого сахарного диабета